CMP-Sialic acid, short for Cytidine Monophosphate-Sialic Acid, is a nucleotide sugar that plays a crucial role as an activated form of sialic acid, which is essential for the biosynthesis of glycoproteins and glycolipids in cells. CMP-Sialic acid is used as a donor substrate in enzymatic reactions that transfer sialic acid to the growing glycan chains of glycoproteins and glycolipids. This process is catalyzed by a group of enzymes known as sialyltransferases. The addition of sialic acid to glycoconjugates is a critical step in the maturation and function of these molecules, influencing their stability, bioactivity, and interactions with other cells and molecules in the biological system. In research and biotechnological applications, CMP-Sialic acid is utilized to study and manipulate glycosylation patterns of proteins and lipids, which is important for understanding disease mechanisms, developing therapeutic interventions, and producing recombinant proteins with specific glycosylation profiles for medical use. For instance, the sialylation of therapeutic proteins can affect their serum half-life, immunogenicity, and biological activity, making the control of this modification crucial for the development of effective biopharmaceuticals.